Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes

Table 7 Operated liver and pancreas cancer postoperative outcomes and stay

Pancreas and liver cancer, all results presented as n (%) unless specified			Pancreas, n = 6	Liver, n = 6
Overall complications	Mortality (CD V)		0 (0)	0 (0)
	Patients with complications		3 (50.0)	4 (66.7)
	Unplanned ICU admission (CD IV)		0	0
	Planned ICU admission		4 (66.7)	4 (66.7)
	Reintervention		1 (16.7) (III-A)	0
	Any major complication (CD III-V)		1 (16.7) III-A	0
	Acute kidney injury		2 (66.7)	2 (50.0)
	Ileus		1 (33.3)	1 (25.0)
	Bleeding requiring transfusion		0	1 (25.0)
	Superficial/Deep SSI		0	1 (25.0)
	Other		2 (66.7)1	0
HBP complications	Postoperative bleeding	No	6 (100)	6 (100)
	Bile leak	No	6 (100)	5 (83.3)
		Grade A	0	1 (16.7)
	Readmission with cholangitis		0	0
Pancreatic specific complications	Postoperative pancreatic fistula	No	6 (100)	-
Liver specific complications	Post-hepatectomy liver failure	No	-	3 (50.0)
		Grade A	-	2 (33.3)
		Grade B	-	1 (16.7)
		Grade C		0
	Length of stay (d)	Mean (SD)	8 (2.37)	6.33 (3.61)

¹Gastric empty delaying and peripheral catheter infection.

HBP: Hepato-Bilio-Pancreatic; CD: Clavien-dindo; SSI: Surgical site infection; ICU: Intensive care unit.